Withdrawal Syndrome Clinical Trial
Official title:
Protocolized Sedative Weaning Versus Usual Care in Pediatric Critically Ill, Randomized Controlled Trial
Sedative and analgesic agents are widely used in the ICU. These agents can provide hypnotic
effect, pain alleviation, cooperation, and synchronizing ventilatory support. Prolonged use
of the agents can lead to withdrawal symptoms when the drugs are weaned.
Prior study showed the longer duration of sedative drugs, cumulative dose of medications and
younger age were the risk factors of withdrawal syndrome. Additional, some study showed the
sedation protocol can reduce the incidence of withdrawal syndrome. However, no worldwide
standardized sedative weaning protocol including our hospital. The objectives in this study
are to establish the sedative weaning protocol and to compare the protocol sedative weaning
with the usual care weaning.
Sedative and analgesic agents, particularly benzodiazepines and opioids, are widely used in
PICU. These agents can provide calmness, hypnotic effect, pain alleviation, cooperation,
immobilization and synchronizing ventilatory support.
Prolonged use of the agents can lead to withdrawal symptoms when the drugs are weaned.
Incidence of withdrawal syndrome is about 50%. Withdrawal syndrome can lead to unnecessary
and costly diagnostic tests, prolongation of mechanical ventilation and hospital stay, and
increasing of suffering. Prior study showed the longer duration of sedative drugs, cumulative
dose of medications and younger age were the risk factors of withdrawal syndrome. Additional,
some study showed the sedation protocol can reduce the incidence of withdrawal syndrome.
However, no worldwide standardized sedative weaning protocol including our hospital.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04422808 -
AduLt iatrogEnic withdRawal sTudy in the ICU (ALERT-ICU)
|
||
| Not yet recruiting |
NCT05512091 -
Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco Use
|
||
| Recruiting |
NCT05883358 -
Kratom Use Disorder Management Using Clonidine and/or Buprenorphine
|
||
| Completed |
NCT03573479 -
Early Rehabilitation in Critically Ill Children - The PICU Liber8 Study
|
||
| Completed |
NCT05336656 -
Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19
|
||
| Completed |
NCT03114904 -
Comparison of the Efficacy of a Protocol for the Withdrawal of Neurosedation From the Usual Strategy in Cerebroses
|
N/A | |
| Terminated |
NCT03645603 -
Efficacy and Safety of Dexmedetomidine During Weaning From Analgesia and Sedation in PICU (TIP-15-01)
|
Phase 2 | |
| Completed |
NCT03996096 -
Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors.
|